10-K Filing

Xenetic Biosciences, Inc. CIK: 1534525 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001683168-18-000831`
Period End Date	20171231
Filing Date	20180330
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	xbio-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 42 Cash Flow Statement 82 Stockholders Equity 23

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Cash	`Cash`	$132.23K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.73M	shares	Point-in-time
Cash	`Cash`	$5.53M	USD	Point-in-time
Cash	`Cash`	$4.05M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.91M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.59M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.41M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.00M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$285.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.22M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.34M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.88M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$42.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.85K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$66.34K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$724.71K	USD	Point-in-time
Total assets	`Assets`	$20.97M	USD	Point-in-time
Total assets	`Assets`	$19.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$786.78K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.01M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.14M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$838.89K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$20.20K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$21.23K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.94M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$19.88K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$4.80M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.86M	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of December 31, 2017 and December 31, 2016; 9,041,426 and 8,731,029 shares issued as of December 31, 2017 and December 31, 2016, respectively; 8,717,541 and 8,407,144 shares outstanding as of December 31, 2017 and December 31, 2016, respectively	`CommonStockValue`	$9.04K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of December 31, 2017 and December 31, 2016; 9,041,426 and 8,731,029 shares issued as of December 31, 2017 and December 31, 2016, respectively; 8,717,541 and 8,407,144 shares outstanding as of December 31, 2017 and December 31, 2016, respectively	`CommonStockValue`	$8.73K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$165.25M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$163.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.93M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-142.34M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.17M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.16M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.97M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Licenses	`LicensesRevenue`	-	USD	Annual
Licenses	`LicensesRevenue`	$7.50M	USD	Annual
Milestones	`ContractsRevenue`	-	USD	Annual
Milestones	`ContractsRevenue`	$3.00M	USD	Annual
Collaboration services	`OtherSalesRevenueNet`	$85.00K	USD	Annual
Collaboration services	`OtherSalesRevenueNet`	-	USD	Annual
Total revenues	`Revenues`	$7.58M	USD	Annual
Total revenues	`Revenues`	$3.00M	USD	Annual
Cost of research and development revenue	`OtherResearchAndDevelopmentExpense`	-	USD	Annual
Cost of research and development revenue	`OtherResearchAndDevelopmentExpense`	$156.12K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.06M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$43.74M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.69M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.94M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.57M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-47.43M	USD	Annual
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	$2.13M	USD	Annual
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	-	USD	Annual
Loss on issuance of hybrid debt instruments	`GainLossOnIssuanceOfHybridDebtInstrument`	-	USD	Annual
Loss on issuance of hybrid debt instruments	`GainLossOnIssuanceOfHybridDebtInstrument`	$-1.69M	USD	Annual
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.39M	USD	Annual
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Other expense	`OtherNonoperatingIncomeExpense`	$-41.10K	USD	Annual
Other expense	`OtherNonoperatingIncomeExpense`	$-85.37K	USD	Annual
Interest income	`InterestIncomeOther`	$16.54K	USD	Annual
Interest income	`InterestIncomeOther`	$32.00	USD	Annual
Interest expense	`InterestExpense`	$1.82K	USD	Annual
Interest expense	`InterestExpense`	$729.57K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-6.78M	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-26.37K	USD	Annual
Net loss	`NetIncomeLoss`	$-3.60M	USD	Annual
Net loss	`NetIncomeLoss`	$-54.21M	USD	Annual
Accretion of beneficial conversion feature on convertible preferred stock	`AccretionExpense`	-	USD	Annual
Accretion of beneficial conversion feature on convertible preferred stock	`AccretionExpense`	$4.04M	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.24M	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.60M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.60M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-54.21M	USD	Annual
Basic and diluted loss per share applicable to common stockholders	`EarningsPerShareBasicAndDiluted`	$-7.84	USD	Annual
Basic and diluted loss per share applicable to common stockholders	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	Annual
Weighted-average shares of common stock outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.43M	shares	Annual
Weighted-average shares of common stock outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.67M	shares	Annual

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.60M	USD	Annual
Net loss	`NetIncomeLoss`	$-54.21M	USD	Annual
In-process research and development expense	`InprocessResearchAndDevelopmentExpense`	$39.50M	USD	Annual
In-process research and development expense	`InprocessResearchAndDevelopmentExpense`	-	USD	Annual
Depreciation	`Depreciation`	$23.78K	USD	Annual
Depreciation	`Depreciation`	$36.45K	USD	Annual
Amortization of hybrid debt instrument discount	`AmortizationOfDebtDiscountPremium`	$544.48K	USD	Annual
Amortization of hybrid debt instrument discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Non-cash interest expense	`OtherNoncashExpense`	$174.52K	USD	Annual
Non-cash interest expense	`OtherNoncashExpense`	-	USD	Annual
Share-based payments	`ShareBasedCompensation`	$1.92M	USD	Annual
Share-based payments	`ShareBasedCompensation`	$1.78M	USD	Annual
Change in value of warrants issued for services	`AdjustmentOfWarrantsGrantedForServices`	$-126.32K	USD	Annual
Change in value of warrants issued for services	`AdjustmentOfWarrantsGrantedForServices`	$1.12M	USD	Annual
Vendor share-based payments	`VendorShareBasedPayments`	$135.28K	USD	Annual
Vendor share-based payments	`VendorShareBasedPayments`	$180.97K	USD	Annual
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$2.13M	USD	Annual
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	Annual
Loss on issuance of hybrid debt instrument	`GainLossOnIssuanceOfHybridDebtInstrument`	-	USD	Annual
Loss on issuance of hybrid debt instrument	`GainLossOnIssuanceOfHybridDebtInstrument`	$-1.69M	USD	Annual
Hybrid debt instrument issuance costs	`PaymentsOfDebtIssuanceCosts`	$12.09K	USD	Annual
Hybrid debt instrument issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.39M	USD	Annual
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Settlement of accounts payable with common stock	`SettlementOfAccountsPayableWithCommonStock`	$243.67K	USD	Annual
Settlement of accounts payable with common stock	`SettlementOfAccountsPayableWithCommonStock`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.00M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-280.63K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$234.92K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.18K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.02M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.49M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.79M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.79K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.26K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.26K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.79K	USD	Annual
Proceeds from issuance of debt	`ProceedsFromIssuanceOfDebt`	$4.50M	USD	Annual
Proceeds from issuance of debt	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Payments on debt	`RepaymentsOfDebt`	$369.96K	USD	Annual
Payments on debt	`RepaymentsOfDebt`	-	USD	Annual
Proceeds from issuance of units in offering	`ProceedsFromIssuanceOfUnitsInOffering`	-	USD	Annual
Proceeds from issuance of units in offering	`ProceedsFromIssuanceOfUnitsInOffering`	$8.97M	USD	Annual
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	$380.17K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.72M	USD	Annual
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$3.92M	USD	Annual
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$1.48M	USD	Annual
Cash at beginning of period	`Cash`	$132.23K	USD	Point-in-time
Cash at beginning of period	`Cash`	$5.53M	USD	Point-in-time
Cash at beginning of period	`Cash`	$4.05M	USD	Point-in-time
Cash at end of period	`Cash`	$132.23K	USD	Point-in-time
Cash at end of period	`Cash`	$5.53M	USD	Point-in-time
Cash at end of period	`Cash`	$4.05M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$1.93K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$15.84K	USD	Annual
Interest paid in common stock	`InterestPaidInCommonStock`	$255.61K	USD	Annual
Interest paid in common stock	`InterestPaidInCommonStock`	-	USD	Annual
Purchase of XBIO IPR&D with common stock	`PurchaseOfXbioRDWithCommonStock`	-	USD	Annual
Purchase of XBIO IPR&D with common stock	`PurchaseOfXbioRDWithCommonStock`	$39.50M	USD	Annual
Issuance of note in settlement of deferred payroll costs	`IssuanceOfNoteInSettlementOfDeferredPayrollCosts`	-	USD	Annual
Issuance of note in settlement of deferred payroll costs	`IssuanceOfNoteInSettlementOfDeferredPayrollCosts`	$369.96K	USD	Annual
Reclassification of related party loan principal to accounts payable	`ReclassificationOfRelatedPartyLoanPrincipalToAccountsPayable`	-	USD	Annual
Reclassification of related party loan principal to accounts payable	`ReclassificationOfRelatedPartyLoanPrincipalToAccountsPayable`	$14.83K	USD	Annual
Exchange of common stock for Series A preferred stock	`ExchangeOfCommonStockForSeriesPreferredStock`	-	USD	Annual
Exchange of common stock for Series A preferred stock	`ExchangeOfCommonStockForSeriesPreferredStock`	$970.00	USD	Annual
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$185.00	USD	Annual
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$119.00	USD	Annual
Convertible debt paid in common stock	`ConvertibleDebtPaidInCommonStock`	-	USD	Annual
Convertible debt paid in common stock	`ConvertibleDebtPaidInCommonStock`	$7.00M	USD	Annual
Convertible debt paid in public offering units	`ConvertibleDebtPaidInPublicOfferingUnites`	$500.00K	USD	Annual
Convertible debt paid in public offering units	`ConvertibleDebtPaidInPublicOfferingUnites`	-	USD	Annual
Issuance of warrants in connection with debt	`NoncashIssuanceOfWarrantsInConnectionWithDebt`	$2.11M	USD	Annual
Issuance of warrants in connection with debt	`NoncashIssuanceOfWarrantsInConnectionWithDebt`	-	USD	Annual
Recording of derivative liability in connection with debt	`NoncashRecordingOfDerivativeLiabilityInConnectionWithDebt`	-	USD	Annual
Recording of derivative liability in connection with debt	`NoncashRecordingOfDerivativeLiabilityInConnectionWithDebt`	$4.12M	USD	Annual
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	-	USD	Annual
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	$65.98K	USD	Annual
Issuance of common stock for promissory note converted	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	-	USD	Annual
Issuance of common stock for promissory note converted	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	$125.00	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$16.17M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$6.61M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time
Issuance of common stock to vendors, value	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.17M	USD	Annual
Warrant expense	`AdjustmentOfWarrantsGrantedForServices`	$-126.32K	USD	Annual
Warrant expense	`AdjustmentOfWarrantsGrantedForServices`	$1.12M	USD	Annual
Issuance of warrants in connection with debt (net of issuance costs of $16,769)	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.07M	USD	Annual
Conversion of notes, value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$12.02M	USD	Annual
Settlement of accrued interest in common stock	`SettlementOfAccruedInterestInCommonStock`	$237.24K	USD	Annual
Issuance of common stock in connection with completion of asset acquisition, value	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$34.90M	USD	Annual
Issuance of warrants in connection with completion of asset acquisition	`IssuanceOfWarrantsInConnectionWithCompletionOfAssetAcquisition`	$853.04K	USD	Annual
Issuance of Series B preferred stock in public offering, value	`IssuanceOfSeriesBPreferredStockInPublicOfferingValue`	$5.71M	USD	Annual
Issuance of warrants in public offering	`IssuanceOfWarrantsInPublicOffering`	$3.76M	USD	Annual
Record beneficial conversion feature in connection with public offering	`RecordBeneficialConversionFeatureInConnectionWithPublicOffering`	$4.04M	USD	Annual
Acrete beneficial conversion feature in connection with public offering	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$4.04M	USD	Annual
Share-based payments	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$1.78M	USD	Annual
Share-based payments	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$1.92M	USD	Annual
Common stock awards to vendors	`CommonStockAwardsToVendors`	$69.30K	USD	Annual
Net loss	`NetIncomeLoss`	$-3.60M	USD	Annual
Net loss	`NetIncomeLoss`	$-54.21M	USD	Annual
Ending balance, value	`StockholdersEquity`	$16.17M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$6.61M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.